Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet randomized trial in end-stage renal disease
2005-003871-19Phase 4Completed
- Sponsor
- Salford Royal Hospital
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cinacalcet in secondary hyperparathyroidism (SHPT) and end-stage kidney disease (ESKD) (2 arms), sponsored by Salford Royal Hospital. Primary endpoint: Percentage change in vascular calcification score. Started Oct 2005; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2005-003871-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003871-19.